Ginkgo biloba as an adjunct to methylphenidate in the treatment of attention deficit hyperactivity disorder in children: review of articles

Hebrani, Paria and Behdani, Fatemeh and Jalayer, Hoda (2015) Ginkgo biloba as an adjunct to methylphenidate in the treatment of attention deficit hyperactivity disorder in children: review of articles. Reviews in Clinical Medicine, 2 (2). pp. 80-83.

[img]
Preview
Text
RCM_Volume 2_Issue 2_Pages 80-83.pdf

Download (302kB) | Preview
Official URL: http://rcm.mums.ac.ir/article_4029.html

Abstract

Attention-deficit/hyperactivity disorder is one of the most common psychiatric disorders in childhood. The medications which inhibit the reuptake of noradrenline and dopamine including psychostimulants such as methylphenidate and dextroamphetamine and non-stimulating pre-frontal cortex noradrenaline reuptake inhibitor such as atomoxetine, are the standard treatment of ADHD. Adverse effects of stimulants have been reported in thirty percent of patients with attention-deficit/hyperactivity disorder. More than fifty percent of the parents of these children have tried one or more complementary or alternative medicines including vitamins in their children. Ginkgo biloba has been described to be effective for various neuropsychiatric symptoms. It was assumed that ginkgo biloba might improve some symptoms of attention deficit disorder as well. Nevertheless, no systematic study reported a possible efficacy of ginkgo biloba in attention deficit disorder. This review article evaluates the available evidence on the efficacy of ginkgo biloba medication in Attention-deficit/hyperactivity disorder children to present an appropriate guidance for this common child disorder.

Item Type: Article
Subjects: WM Psychiatry
WS Pediatrics
Divisions: Journals > Reviews in Clinical Medicine
Depositing User: RCM RCM
Date Deposited: 04 Oct 2017 03:34
Last Modified: 04 Oct 2017 03:34
URI: http://eprints.mums.ac.ir/id/eprint/7488

Actions (login required)

View Item View Item